Gianluigi Guida
Do you need an appointment?
Biography
Dr. Gianluigi Guida is a cardiologist specialized in Cardiovascular Diseases at IRCCS Policlinico San Donato, where he works within the University Cardiology Unit directed by Professor Massimo Piepoli and the Multimodality Cardiac Imaging Unit, focusing on the clinical and diagnostic management of patients with heart failure and cardiomyopathies.
After obtaining his MD degree in Medicine and Surgery in July 2017 from the Università Cattolica del Sacro Cuore with top marks and honors, he completed his specialization in Cardiovascular Diseases in 2022 at the University of Pavia, defending a thesis on the prognostic role of cardiac magnetic resonance in Fabry disease.
During his specialization, he mainly focused on heart failure and multimodality imaging, with particular expertise in transthoracic echocardiography, transesophageal echocardiography, and cardiac magnetic resonance. He also completed a fellowship in Cardiac Magnetic Resonance at the Multimodality Cardiac Imaging Unit of IRCCS Policlinico San Donato, further strengthening his experience in this field.
He is currently involved in the clinical management of patients with dilated and hypertrophic cardiomyopathies, cardiac amyloidosis, Fabry disease, and arrhythmogenic cardiomyopathies, overseeing both clinical and imaging aspects. Previously, he worked as a cardiologist at the National Referral Center for Systemic Amyloidosis at Policlinico San Matteo in Pavia, where he gained in-depth experience in the diagnosis and management of these complex cardiomyopathies.
His main cardiology interests focus on heart failure and cardiomyopathies, with particular attention to the use of advanced imaging techniques for myocardial disease characterization.
He is a Fellow of the Heart Failure Association (HFA), a Committee Member of HFA Prevention, and Social Media Manager of the European Heart Journal – Quality of Care and Clinical Outcomes.
He has participated as a sub-investigator in several pharmacological clinical trials involving patients with cardiac amyloidosis and is currently involved in clinical trials on hypertrophic cardiomyopathy and heart failure, as well as in investigator-initiated research projects at IRCCS Policlinico San Donato.